Improvement of antibody functionality by structure-guided paratope engraftment (Q61796303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

title

Improvement of antibody functionality by structure-guided paratope engraftment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Yen-Ting Lai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Mark K. Louder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Xuejun Chen

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Paolo Lusso

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

14

Anthony S Fauci

1 reference

23 April 2020

15

Peter D Kwong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

16

John R Mascola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

5

Amarendra Pegu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

9

Chen-Hsiang Shen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

6

Reda Rawi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Mangaiarkarasi Asokan

7

object named as

Mangaiarkarasi Asokan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

12

Huiyi Miao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

author name string

Peng Zhang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Gwo-Yu Chuang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Eun Sung Yang

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

Yuge Wang

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

language of work or name

English

0 references

publication date

13 February 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

published in

Nature Communications

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

page(s)

721

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

23 April 2020

copyright license

start time

13 February 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-gp120 interface

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Antibodies in HIV-1 vaccine development and therapy

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Lessons from HIV-1 vaccine efficacy trials

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

HIV-1 neutralizing antibodies: understanding nature's pathways

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

HIV-1 neutralizing antibodies display dual recognition of the primary and coreceptor binding sites and preferential binding to fully cleaved envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Global panel of HIV-1 Env reference strains for standardized assessments of vaccine-elicited neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Half-life of polyreactive antibodies

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Maturation and Diversity of the VRC01-Antibody Lineage over 15 Years of Chronic HIV-1 Infection

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Secondary mechanisms of diversification in the human antibody repertoire.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Enhanced potency of a broadly neutralizing HIV-1 antibody in vitro improves protection against lentiviral infection in vivo

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Immunoglobulin gene insertions and deletions in the affinity maturation of HIV-1 broadly reactive neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Bispecific Anti-HIV-1 Antibodies with Enhanced Breadth and Potency

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

A functional antibody mutant with an insertion in the framework region 3 loop of the VH domain: implications for antibody engineering

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

An Insertion Mutation That Distorts Antibody Binding Site Architecture Enhances Function of a Human Antibody

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1.

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

SeqFeatR for the Discovery of Feature-Sequence Associations

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Gene-Specific Substitution Profiles Describe the Types and Frequencies of Amino Acid Changes during Antibody Somatic Hypermutation

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

IgBLAST: an immunoglobulin variable domain sequence analysis tool

1 reference

https://api.crossref.org/works/10.1038/S41467-019-08658-4

7 January 2021

10.1038/S41467-019-08658-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

Dimensions Publication ID

23 April 2020

ADS bibcode

2019NatCo..10..721L

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30760721 AND SRC:MED&resulttype=core&format=json

23 April 2020

PubMed publication ID

30760721

1 reference